Charter Communications (CHTR) Hit By Guggenheim Downgrade; Capital International Investors Has Decreased Abbvie (ABBV) Holding

August 4, 2017 - By Richard Conner

Among 23 analysts covering Charter Comm (NASDAQ:CHTR), 15 have Buy rating, 0 Sell and 8 Hold. Therefore 65% are positive. Charter Comm has $410 highest and $204 lowest target. $320.29’s average target is -16.66% below currents $384.3 stock price. Charter Comm had 44 analyst reports since August 5, 2015 according to SRatingsIntel. The rating was initiated by HSBC on Thursday, January 19 with “Hold”. The rating was downgraded by Moffett Nathanson on Tuesday, October 11 to “Neutral”. The stock of Charter Communications, Inc. (NASDAQ:CHTR) has “Strong Buy” rating given on Wednesday, June 1 by Raymond James. The rating was upgraded by MoffettNathanson on Wednesday, August 19 to “Neutral”. The rating was maintained by Pivotal Research on Tuesday, May 24 with “Buy”. The stock of Charter Communications, Inc. (NASDAQ:CHTR) has “Overweight” rating given on Tuesday, June 14 by Morgan Stanley. The rating was maintained by Telsey Advisory Group on Monday, November 2 with “Outperform”. As per Tuesday, August 16, the company rating was maintained by Barclays Capital. The stock has “Outperform” rating by RBC Capital Markets on Tuesday, December 6. The rating was maintained by Deutsche Bank with “Buy” on Thursday, August 11.

Capital International Investors decreased Abbvie Inc (ABBV) stake by 40% reported in 2016Q4 SEC filing. Capital International Investors sold 2.20 million shares as Abbvie Inc (ABBV)’s stock rose 6.17%. The Capital International Investors holds 3.30 million shares with $206.90 million value, down from 5.51M last quarter. Abbvie Inc now has $112.98B valuation. The stock increased 0.40% or $0.28 during the last trading session, reaching $70.99. About 1,050 shares traded. AbbVie Inc (NYSE:ABBV) has risen 10.63% since August 4, 2016 and is uptrending. It has underperformed by 6.07% the S&P500.

Since February 28, 2017, it had 0 insider purchases, and 10 selling transactions for $28.02 million activity. 43,000 AbbVie Inc (NYSE:ABBV) shares with value of $2.88M were sold by ALBAN CARLOS. CHASE WILLIAM J sold $2.50 million worth of stock. HURWICH THOMAS A. sold $143,031 worth of stock. On Friday, March 10 the insider Michael Robert A. sold $335,068. 22,451 shares valued at $1.47M were sold by RICHMOND TIMOTHY J. on Friday, March 10. Schumacher Laura J also sold $5.59 million worth of AbbVie Inc (NYSE:ABBV) shares. GONZALEZ RICHARD A sold $4.67 million worth of stock.

Investors sentiment decreased to 0.98 in Q4 2016. Its down 0.05, from 1.03 in 2016Q3. It worsened, as 86 investors sold ABBV shares while 555 reduced holdings. 99 funds opened positions while 531 raised stakes. 1.03 billion shares or 0.70% less from 1.04 billion shares in 2016Q3 were reported. Perkins Management Lc invested in 62,995 shares or 0.05% of the stock. Valley National Advisers reported 20,914 shares stake. Stock Yards Savings Bank & Tru stated it has 0.34% in AbbVie Inc (NYSE:ABBV). American Mgmt Co holds 2,780 shares or 0.06% of its portfolio. Adams Diversified Equity Fund Incorporated invested in 1.47% or 380,000 shares. Bruce And has 232,915 shares. Security National Bank Of Sioux City Iowa Ia has invested 1.02% in AbbVie Inc (NYSE:ABBV). Tcw invested 0.07% of its portfolio in AbbVie Inc (NYSE:ABBV). Credit Suisse Ag reported 4.24M shares or 0.26% of all its holdings. Tdam Usa holds 1.56% or 475,347 shares in its portfolio. Atwood Palmer Inc owns 150 shares for 0% of their portfolio. Pure Fincl Inc holds 0.2% or 10,646 shares in its portfolio. 61,502 are owned by Winslow Evans And Crocker. Clean Yield Group holds 0.22% of its portfolio in AbbVie Inc (NYSE:ABBV) for 7,678 shares. Farr Miller & Washington Ltd Dc has 10,606 shares.

Capital International Investors increased Cerner Corporation (NASDAQ:CERN) stake by 7,459 shares to 3.94M valued at $186.62 million in 2016Q4. It also upped America Movil Sab De Cv L Adr (NYSE:AMX) stake by 232,293 shares and now owns 28.59 million shares. Monsanto Co (NYSE:MON) was raised too.

Among 18 analysts covering Abbvie Inc (NYSE:ABBV), 7 have Buy rating, 1 Sell and 10 Hold. Therefore 39% are positive. Abbvie Inc had 45 analyst reports since July 21, 2015 according to SRatingsIntel. The company was maintained on Friday, July 14 by Jefferies. The stock has “Buy” rating by Jefferies on Thursday, May 25. The rating was upgraded by Jefferies on Monday, December 7 to “Buy”. Citigroup upgraded AbbVie Inc (NYSE:ABBV) on Tuesday, February 23 to “Buy” rating. Deutsche Bank initiated AbbVie Inc (NYSE:ABBV) on Tuesday, March 15 with “Hold” rating. BMO Capital Markets maintained it with “Hold” rating and $63 target in Friday, April 28 report. UBS maintained AbbVie Inc (NYSE:ABBV) rating on Friday, October 23. UBS has “Buy” rating and $78 target. The company was maintained on Thursday, July 20 by Credit Suisse. The firm earned “Sell” rating on Wednesday, April 6 by Societe Generale. The rating was downgraded by JP Morgan on Thursday, September 8 to “Neutral”.

Since February 21, 2017, it had 0 insider purchases, and 3 sales for $8.76 million activity. 6,000 Charter Communications, Inc. (NASDAQ:CHTR) shares with value of $1.95 million were sold by Hargis Jonathan. On Wednesday, May 10 Jacobson Craig A sold $323,617 worth of Charter Communications, Inc. (NASDAQ:CHTR) or 1,000 shares.